HepArrest

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHepArrest
Drug Alias Nameheparin antagonist (CBI)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBlood coagulation stimulantsHeparin antagonists
TargetsHeparin
Therapy Area/IndicationsBlood Coagulation Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInhibitor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInhibitor Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsBlood Coagulation Disorders

Other Information

ATC CodeN/A
Related LinksN/A